Miyazawa, K <br/><br/>
Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice.  [electronic resource] 

 -  Journal of orthopaedic research : official publication of the Orthopaedic Research Society  May 1997 
 - 456-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0736-0266 
<br/><br/><label>Standard No.: </label>10.1002/jor.1100150320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Development--drug effects<br/>Bone Morphogenetic Proteins--pharmacology<br/>Bone Remodeling--drug effects<br/>Capsules<br/>Cell Division--drug effects<br/>Female<br/>Heterozygote<br/>Humans<br/>Macrophage Colony-Stimulating Factor--pharmacology<br/>Male<br/>Mice<br/>Mice, Mutant Strains<br/>Muscle, Skeletal--blood supply<br/>Osteoclasts--cytology<br/>Osteopetrosis--diagnostic imaging<br/>Radiography<br/>Recombinant Proteins--pharmacology<br/>Thrombosis--drug therapy<br/>Tibia--diagnostic imaging